Molnunat 200mg Capsule
Marketer
Natco Pharma Ltd
Salt Composition
Molnupiravir (200mg)
Overview Molnunat 200mg Capsule
For adults with mild to moderate COVID-19, Molnunat 200mg capsules offer the first oral antiviral treatment. Its mechanism involves inhibiting viral replication, thus lessening viral burden and disease intensity. Granted emergency authorization by Indian regulators on December 28, 2021, Molnunat 200mg capsules are prescribed only for high-risk individuals with mild to moderate symptoms—those with obesity, age over 60, diabetes, or cardiac conditions. It's unsuitable for patients needing immediate hospitalization. The U.S. FDA and the UK's regulatory body have also granted emergency use approval. The oral course is limited to five consecutive days; completion of the full five days is crucial, regardless of symptom improvement. Potential side effects include dizziness, headaches, diarrhea, and nausea. Report any adverse effects to your physician for management or preventative strategies. Prior to commencing treatment, disclose all existing health issues and medications to your doctor to ensure safety. Use in pregnant women is discouraged; pregnant and breastfeeding individuals require medical consultation before use.
Uses of Molnunat 200mg Capsule
Managing mild-to-moderate cases of COVID-19
Major Benefits of Molnunat 200mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The 200mg Molnunat capsule can be administered with or without food, although consistent timing is recommended.
Common Side effects of Molnunat 200mg Capsule:
- Nausea
- Dizziness
- Diarrhea
How to use Molnunat 200mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Molnunat 200mg Capsules can be ingested with or without food; however, consistent timing is recommended.
How Molnunat 200mg Capsule works:
Each Molnupiravir 200mg capsule is an antiviral medication that functions by preventing SARS-CoV-2 replication. This action suppresses viral proliferation, thereby reducing the overall viral burden within the patient.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction of Molnupiravir 200mg capsules with alcohol is currently undetermined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Molnunat 200mg capsules during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against possible risks prior to prescribing this medication. Patient consultation with their doctor is advised.
Breast feedingUNSAFE
Lactation is contraindicated with Molnunat 200mg capsules due to potential infant toxicity.
DrivingCONSULT YOUR DOCTOR
The effect of Molnupiravir 200mg capsules on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Molnupiravir 200mg capsules can be administered to patients with renal impairment without modification of the prescribed dosage.
LiverSAFE IF PRESCRIBED
Molnupiravir 200mg capsules may be administered to patients with hepatic impairment without dosage modification.
What if you forget to take Molnunat 200mg Capsule :
Omit a Molnupiravir 200mg capsule? Seek your physician's advice.
Facts to Know About Molnunat 200mg Capsule
| Label | Value |
|---|---|
| Chemical Classification | Cytosine Bases |
| Developing Habits | No. |
| Type of Therapy | Antimicrobials |
| Behavioral Class | Non-HIV antiviral medications |
3,018 People bought this recently